In vitro and in vivo evaluation of biologically synthesized silver nanoparticles for topical applications: Effect of surface coating and loading into hydrogels

International Journal of Nanomedicine

Volumn 12, Issue , 2017, Pages 759-777

  Mekkawy, Aml I ^a   El Mokhtar, Mohamed A ^b   Nafady, Nivien A ^c   Yousef, Naeima ^c   Hamad, Mostafa ^b   El Shanawany, Sohair M ^d   Ibrahim, Ehsan H ^d   Elsabahy, Mahmoud ^d,e,f,g  

^a Sohag University   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

^c Assiut University   (Egypt)

^d Assiut University   (Egypt)

^e ASSIUT UNIVERSITY   (Egypt)

^f TEXAS A AND M UNIVERSITY   (United States)

^g MISR UNIVERSITY FOR SCIENCE AND TECHNOLOGY   (Egypt)

Author keywords

Antibacterial activity; Coating agents; Green synthesis; Hydrogel; Silver nanoparticles; Wound healing

Indexed keywords

ALGINIC ACID; BETA CYCLODEXTRIN DERIVATIVE; CARBOXYMETHYLCELLULOSE; CHITOSAN; DODECYL SULFATE SODIUM; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; POLOXAMER; SILVER NANOPARTICLE; SILVER NITRATE; SULFADIAZINE SILVER; WOUND HEALING PROMOTING AGENT; ANTIINFECTIVE AGENT; BIOCOMPATIBLE COATED MATERIAL; HYDROGEL; METAL NANOPARTICLE; SILVER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; ESCHERICHIA COLI; FEMALE; FUSARIUM VERTICILLIOIDES; GREEN CHEMISTRY; HAIR GROWTH; HUMAN; HUMAN TISSUE; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; NORMAL SKIN APPEARANCE; RAT; SEDIMENTATION; SKIN INJURY; TOPICAL DRUG ADMINISTRATION; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; WATER LOADING; WOUND HEALING; ANIMAL; CHEMISTRY; DRUG EFFECTS; FUSARIUM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PARTICLE SIZE; PATHOLOGY; SKIN; STATIC ELECTRICITY; ULTRASTRUCTURE; ULTRAVIOLET SPECTROPHOTOMETRY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; COATED MATERIALS, BIOCOMPATIBLE; ESCHERICHIA COLI; FEMALE; FUSARIUM; HYDROGELS; METAL NANOPARTICLES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICROBIAL SENSITIVITY TESTS; PARTICLE SIZE; SILVER; SKIN; SPECTROPHOTOMETRY, ULTRAVIOLET; STATIC ELECTRICITY; WOUND HEALING;

EID: 85011580166     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S124294     Document Type: Article

References (76)

1. Birla SS, Tiwari VV, Gade AK, Ingle AP, Yadav AP, Rai MK. Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol. 2009;48(2): 173-179.
2. Brandt O, Mildner M, Egger AE, et al. Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine. Nanomedicine. 2012;8(4): 478-488.
3. Gurunathan S, Han JW, Kwon DN, Kim JH. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett. 2014;9(1): 373.
4. Keat CL, Aziz A, Eid AM, Elmarzugi NA. Biosynthesis of nanoparticles and silver nanoparticles. Bioresour Bioprocess. 2015;2(47): 1-11.
5. Vasilev K, Cook J, Griesser HJ. Antibacterial surfaces for biomedical devices. Expert Rev Med Devices. 2009;6(5): 553-567.
6. Webb GF, D’Agata EM, Magal P, Ruan S. A model of antibiotic-resistant bacterial epidemics in hospitals. Proc Natl Acad Sci U S A. 2005;102(37): 13343-13348.
7. Bustos-Martínez JA, Hamdan-Partida A, Gutiérrez-Cárdenas M. Staphylococcus aureus: la reemergencia de un patógeno en la comunidad [Staphylococcus aureus: the reemergence of a pathogen in the community]. Rev Biomed. 2006;17: 287-305. Spanish.
8. Ayala-Núñez NV, Villegas HHL, Turrent LdCI, Padilla CR. Silver nanoparticles toxicity and bactericidal effect against methicillin-resistant Staphylococcus aureus: nanoscale does matter. NanoBiotechnology. 2009;5(1): 2-9.
9. Alexander JW. History of the medical use of silver. Surg Infect (Larchmt). 2009;10(3): 289-292.
10. Jaiswal S, Duffy B, Jaiswal AK, Stobie N, McHale P. Enhancement of the antibacterial properties of silver nanoparticles using beta-cyclodextrin as a capping agent. Int J Antimicrob Agents. 2010;36(3): 280-283.
11. Khatami M, Pourseyedi S, Khatami M, Hamidi H, Zaeifi M, Soltani L. Synthesis of silver nanoparticles using seed exudates of Sinapis arvensis as a novel bioresource and evaluation of their antifungal activity. Bioresour Bioprocess. 2015;2(19): 1-7.
12. Li WR, Xie XB, Shi QS, Duan SS, Ouyang YS, Chen YB. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. BioMetals. 2011;24(1): 135-141.
13. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1): 76-83.
14. Gong P, Li H, He X, et al. Preparation and antibacterial activity of Fe3O4@Ag nanoparticles. Nanotechnology. 2007;18(28): 285604.
15. Percival SL, Bowler PG, Dolman J. Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J. 2007;4(2): 186-191.
16. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007;73(6): 1712-1720.
17. Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother. 2008;61(4): 869-876.
18. Zhao G, Stevens SJ Jr. Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion. BioMetals. 1998;11(1): 27-32.
19. Kvitek L, Panáček A, Soukupová J, et al. Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). J Phys Chem C. 2008;112(15): 5825-5834.
20. Rahisuddin, AL-Thabaiti SA, Khan Z, Manzoor N. Biosynthesis of silver nanoparticles and its antibacterial and antifungal activities towards Gram-positive, Gram-negative bacterial strains and different species of Candida fungus. Bioprocess Biosyst Eng. 2015;38(9): 1773-1781.
21. Pérez-Díaz M, Alvarado-Gomez E, Magaña-Aquino M, et al. Anti biofilm activity of chitosan gels formulated with silver nanoparticles and their cytotoxic effect on human fibroblasts. Mater Sci Eng C Mater Biol Appl. 2016;60: 317-323.
22. Abid JP, Wark AW, Brevetb PF, Girault HH. Preparation of silver nanoparticles in solution from a silver salt by laser irradiation. Chem Commun (Camb). 2002;7(7): 792-793.
23. Andrade PF, de Faria AF, da Silva DS, Bonacin JA, Gonçalves Mdo C. Structural and morphological investigations of β-cyclodextrin-coated silver nanoparticles. Colloids Surf B Biointerfaces. 2014;118: 289-297.
24. Jadhav K, Dhamecha D, Bhattacharya D, Patil M. Green and ecofriendly synthesis of silver nanoparticles: characterization, biocompatibility studies and gel formulation for treatment of infections in burns. J Photochem Photobiol B. 2016;155: 109-115.
25. Kalishwaralal K, Deepak V, Ramkumarpandian S, Nellaiah H, Sangiliyandi G. Extracellular biosynthesis of silver nanoparticles by the culture supernatant of Bacillus licheniformis. Mater Lett. 2008;62(29): 4411-4413.
26. Nogueira PFM, Paino IMM, Zucolotto V. Nanosilver: properties, applications and impacts on health and environment. Vigil Sanit Debate. 2013;1(4): 59-71.
27. Rowe RC, Sheskey PJ, Owen SC, editors. Handbook of Pharmaceutical Excipients. 5th ed. London: Pharmaceutical Press; 2006.
28. Stevenson AP, Blanco Bea D, Civit S, Antoranz Contera S, Iglesias Cerveto A, Trigueros S. Three strategies to stabilise nearly monodispersed silver nanoparticles in aqueous solution. Nanoscale Res Lett. 2012;7(1): 151.
29. Das A, Kumar A, Patil NB, Viswanathan C, Ghosh D. Preparation and characterization of silver nanoparticle loaded amorphous hydrogel of carboxymethylcellulose for infected wounds. Carbohydr Polym. 2015;130: 254-261.
30. Naraginti S, Kumari PL, Das RK, Sivakumar A, Patil SH, Andhalkar VV. Amelioration of excision wounds by topical application of green synthesized, formulated silver and gold nanoparticles in albino Wistar rats. Mater Sci Eng C Mater Biol Appl. 2016;62: 293-300.
31. Abdel-Hafez SI, Nafady NA, Abdel-Rahim IR, Shaltout AM, Mohamed MA. Biogenesis and optimisation of silver nanoparticles by the endophytic fungus Cladosporium sphaerospermum. Int J Nano Chem. 2016;2(1): 11-19.
32. Hoa LTM, Dung TT, Danh TM, Duc NH, Chien DM. Preparation and characterization of magnetic nanoparticles coated with polyethylene glycol. J Phys Conf Ser. 2009;187(1): 012048.
33. Yu M, Huang S, Yu KJ, Clyne AM. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D Cell Culture. Int J Mol Sci. 2012;13(5): 5554-5570.
34. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition. Vol 32. CLSI document M07-A9. Wayne, PA: CLSI; 2012.
35. Kora AJ, Manjusha R, Arunachalam J. Superior bactericidal activity of SDS capped silver nanoparticles: synthesis and characterization. Mater Sci Eng C Mater Biol Appl. 2009;29(7): 2104-2109.
36. Thekkae Padil VV, Černík M. Green synthesis of copper oxide nanoparticles using gum karaya as a biotemplate and their antibacterial application. Int J Nanomedicine. 2013;8: 889-898.
37. Islam MT, Rodríguez-Hornedo N, Ciotti S, Ackermann C. Rheological characterization of topical carbomer gels neutralized to different pH. Pharm Res. 2004;21(7): 1192-1199.
38. Jungermann E, Sonntag NOV, editors. Glycerine: A Key Cosmetic Ingredient. New York: Marcel Dekker, Inc; 1991.
39. Schmolka IR. Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res. 1972;6(6): 571-582.
40. El-Houssieny BM, Hamouda HM. Formulation and evaluation of clotrimazole from pluronic F127 gels. Drug Discov Ther. 2010;4(1): 33-43.
41. Dai T, Tegos GP, Zhiyentayev T, Mylonakis E, Hamblin MR. Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg Med. 2010;42(1): 38-44.
42. Tian J, Wong KK, Ho CM, et al. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem. 2007;2(1): 129-136.
43. Ali SM, Yousef NMH, Nafady NA. Application of biosynthesized silver nanoparticles for the control of land snail Eobania vermiculata and some plant pathogenic fungi. J Nanomater. 2015;2015(3): 1-10.
44. SPSS for windows, release 17.0.0 [computer program]. Chicago, IL: SPSS Inc; 2008.
45. Shenashen MA, El-Safty SA, Elshehy EA. Synthesis, morphological control, and properties of silver nanoparticles in potential applications. Part Part Syst Charact. 2014;31(3): 293-316.
46. Ahmad A, Mukherjee P, Senapati S, et al. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surf B Biointerfaces. 2003;28(4): 313-318.
47. Durán N, Marcato PD, Alves OL, Souza GI, Esposito E. Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains. J Nanobiotechnology. 2005;3: 8.
48. Kumar SA, Abyaneh MK, Gosavi SW, et al. Nitrate reductase-mediated synthesis of silver nanoparticles from AgNO3. Biotechnol Lett. 2007;29(3): 439-445.
49. Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya RH. Biomimetics of silver nanoparticles by white rot fungus, Phaenerochaete chrysosporium. Colloids Surf B Biointerfaces. 2006;53(1): 55-59.
50. Premasudha P, Venkataramana M, Abirami M, Vanathi P, Krishna K, Rajendran R. Biological synthesis and characterization of silver nanoparticles using Eclipta alba leaf extract and evaluation of its cytotoxic and antimicrobial potential. Bull Mater Sci. 2015;38(4): 965-973.
51. Ma R, Levard C, Marinakos SM, et al. Size-controlled dissolution of organic-coated silver nanoparticles. Environ Sci Technol. 2012;46(2): 752-759.
52. Dounighi MN, Eskandari R, Avadi MR, Zolfagharian H, Mir Mohammad Sadeghi A, Rezayat M. Preparation and in vitro characterization of chitosan nanoparticles containing Mesobuthus Eupeus scorpion venom as an antigen delivery system. J Venom Anim Toxins Incl Trop Dis. 2012;18(1): 44-52.
53. Sahu BP, Das MK. Preparation and in vitro/in vivo evaluation of felodipine nanosuspension. Eur J Drug Metab Pharmacokinet. 2014;39(3): 183-193.
54. Sundararajan B, Mahendran G, Thamaraiselvi R, Kumari BR. Biological activities of synthesized silver nanoparticles from Cardiospermum halicacabum L. Bull Mater Sci. 2016;39(2): 423-431.
55. Li X, Lenhart JJ, Walker HW. Aggregation kinetics and dissolution of coated silver nanoparticles. Langmuir. 2012;28(2): 1095-1104.
56. Stiufiuc R, Iacovita C, Lucaciu CM, et al. SERS-active silver colloids prepared by reduction of silver nitrate with short-chain polyethylene glycol. Nanoscale Res Lett. 2013;8(1): 47.
57. Ansari MA, Khan HM, Khan AA, et al. Evaluation of antibacterial activity of silver nanoparticles against MSSA and MRSA on isolates from skin infections. Biol Med. 2011;3(2): 141-146.
58. Martínez-Castañón GA, Niño-Martínez N, Martínez-Gutierrez F, Martínez-Mendoza JR, Ruiz F. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanopart Res. 2008;10(8): 1343-1348.
59. Thiel J, Pakstis L, Buzby S, et al. Antibacterial properties of silver-doped titania. Small. 2007;3(5): 799-803.
60. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3(1): 95-101.
61. Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology. 2007;18(22): 225103.
62. Ojha AK, Forster S, Kumar S, Vats S, Negi S, Fischer I. Synthesis of well-dispersed silver nanorods of different aspect ratios and their antimicrobial properties against Gram positive and negative bacterial strains. J Nanobiotechnology. 2013;11: 42.
63. Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater. 2008;4(3): 707-716.
64. Guvendiren M, Lu HD, Burdick JA. Shear-thinning hydrogels for biomedical applications. Soft Matter. 2012;8(2): 260-272.
65. Mekkawy A, Fathy M, El-Shanawany S. Formulation and in vitro evaluation of fluconazole topical gels. Br J Pharm Res. 2013;3(3): 293-313.
66. Bibby DC, Davies NM, Tucker IG. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm. 2000;197(1-2): 1-11.
67. Izawa H, Kawakami K, Sumita M, Tateyama Y, Hill JP, Ariga K. β-Cyclodextrin-crosslinked alginate gel for patient-controlled drug delivery systems: regulation of host-guest interactions with mechanical stimuli. J Mater Chem B. 2013;1(16): 2155-2161.
68. Sajomsanga W, Nuchuchuaa O, Gonila P, et al. Water-soluble β-cyclodextrin grafted with chitosan and its inclusion complex as a mucoadhesive eugenol carrier. Carbohydr Polym. 2012;89(2): 623-631.
69. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 2005;6(2): E329-E357.
70. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9: 283-289.
71. Liu X, Lee PY, Ho CM, et al. Silver nanoparticles mediate differential responses in keratinocytes and fibroblasts during skin wound healing. ChemMedChem. 2010;5(3): 468-475.
72. Franková J, Pivodová V, Vágnerová H, Juráňová J, Ulrichová J. Effects of silver nanoparticles on primary cell cultures of fibroblasts and keratinocytes in a wound-healing model. J Appl Biomater Funct Mater. 2016;14(2): e137-e142.
73. Szmyd R, Goralczyk AG, Skalniak L, et al. Effect of silver nanoparticles on human primary keratinocytes. Biol Chem. 2013;394(1): 113-123.
74. Nam G, Rangasamy S, Purushothaman B, Song JM. The application of bactericidal silver nanoparticles in wound treatment. Nanomater Nanotechnol. 2015;5(23): 1-14.
75. Hendi A. Silver nanoparticles mediate differential responses in some of liver and kidney functions during skin wound healing. J King Saud Univ Sci. 2011;23(1): 47-52.
76. Pène J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol. 2008;180(11): 7423-7430.